Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]

COVID-19: Management of non-small cell lung cancer patients during the...

Dr Heather Wakelee - Stanford University, Stanford, USA

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic ( Dr Heather Wakelee - Stanford University, Stanford, USA )

Managing toxicities associated with immune-checkpoint inhibitors

Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France

Managing toxicities associated with immune-checkpoint inhibitors ( Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France )

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk...

Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer ( Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA )

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients...

Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )

An oncologist's experience of managing breast cancer during the COVID-19...

Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy

An oncologist's experience of managing breast cancer during the COVID-19 outbreak ( Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy )

COVID-19: The situation in Florida and managing lung cancer patients

Dr. Luis Raez - Memorial Healthcare System, Florida, Miami

COVID-19: The situation in Florida and managing lung cancer patients ( Dr. Luis Raez - Memorial Healthcare System, Florida, Miami )

The potential of KRAS inhibitors for non-small-cell lung cancer

Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany

The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )

Using cancer research strategies to develop an anti-coronavirus vaccine

Dr Bernard Fox - Providence Cancer Institute, Portland, USA

Using cancer research strategies to develop an anti-coronavirus vaccine ( Dr Bernard Fox - Providence Cancer Institute, Portland, USA )

Managing multiple myeloma during the COVID-19 outbreak

Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA

Managing multiple myeloma during the COVID-19 outbreak ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )

Novel treatment strategies for prostate cancer: Senescence, senolytics and...

Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland

Novel treatment strategies for prostate cancer: Senescence, senolytics and myeloid derived suppressor cells ( Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland )

Immune checkpoint based approaches in AML and MDS

Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA

Immune checkpoint based approaches in AML and MDS ( Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA )

CARTs for the treatment of T-cell malignancies

Dr John DiPersio - Siteman Cancer Center, St. Louis, USA

CARTs for the treatment of T-cell malignancies ( Dr John DiPersio - Siteman Cancer Center, St. Louis, USA )

More from ecancer